StockData

Can B Corp (NASC) stock

NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2024, quý kết thúc ngày Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)

Close on Oct 19, 2026Market cap $981.54KP/E –Yield –

Can B Corp saw revenue fall 57.7% to $1.03M over the twelve months to Sep 30, 2024. Free cash flow was -$1.32M. At the latest close the market valued the company at $981.54K.

Revenue
$1.03M
-57.7% vs. a year earlier
Operating income
-$10.71M
TTM Q3 2024
Free cash flow
-$1.32M
FY2023
EPS, diluted
-$0.77
FY2023

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2024

Valuation

Market cap
$981.54K
P/E ratio
–
Price to sales
0.95
Price to book
–
Dividend yield
–
Free cash flow yield
-134.43%

Fundamentals

Revenue
$1.03M
Net income
-$13.26M
EPS, diluted
-$0.77
Free cash flow
-$1.32M
Book value per share
-$0.15
Diluted shares
65M

Trading

Previous close
$0.02
Open
$0.01
Day's range
$0.01 – $0.01
Volume
60,817
Average volume (20 days)
75,608

Market cap history

Month-end market cap since 2016, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodNASCS&P 500DifferenceNASC per yearS&P 500 per year
1 month+44.2%+0.6%+43.6 pts
3 months+15.4%+3.4%+12.0 pts
Year to date-7.0%+13.3%−20.3 pts
1 year-25.0%+16.6%−41.6 pts
3 years-78.6%+86.4%−164.9 pts-40.2%+23.1%
5 years-99.9%+81.9%−181.7 pts-73.1%+12.7%
10 years-100.0%+318.9%−418.8 pts-61.5%+15.4%

Ten years at a glance

Fiscal years 2014 to 2023 and trailing twelve months, USD

Revenue

$1.03M-57.7% YoY

Gross profit

-$343.30K

Operating income

-$10.71M

Net income

-$13.26M

EPS, diluted

–

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases Can B filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. Update

About Can B

Wholesale-Drugs, Proprietaries & Druggists' Sundries

Can B Corp is a health and wellness company that develops, manufactures, and sells hemp-derived cannabinoid products and distributes durable medical equipment. Its product offerings include cannabidiol tinctures, topicals, capsules, and minor cannabinoid isolates and isomers, marketed under brands such as Canbiola and Pure Leaf Oil. The company also supplies durable medical devices, such as ultrasound therapy units and back support braces, intended to assist post-surgery recovery and pain relief. Its customers include retail consumers, medical professionals, doctor offices, and wholesale clients.

Company profile, executives and history

Can B stock: common questions

What is Can B's stock price?

NASC closed at $0.01 on Oct 19, 2026, down 1.32% on the day.

What is Can B's market cap?

Can B was worth $981.54K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is NASC's P/E ratio?

Can B lost money over fiscal 2023 (diluted EPS -$0.77), so it has no meaningful P/E ratio.

How much revenue does Can B make?

Can B reported revenue of $1.03M for the twelve months to Sep 30, 2024, down 57.7% from a year earlier.

Does Can B pay a dividend?

No. Can B has not paid a cash dividend over the last twelve months.

How has NASC stock performed over the past year?

Including dividends, NASC returned -25.0% over the past year, against +16.6% for the S&P 500.

Who are Can B's competitors?

Companies most similar to Can B by business, industry and size include STEK, NUS, COSM, HLF, COR.

See a number that looks wrong?